Shifting Beyond Classical Drug Synergy in Combinatorial Therapy through Solubility Alterations

Shifting Beyond Classical Drug Synergy in Combinatorial Therapy through Solubility Alterations | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Article Shifting Beyond Classical Drug Synergy in Combinatorial Therapy through Solubility Alterations Mohieddin Jafari, Elham Gholizadeh, Ehsan Zangene, Uladzislau Vadadokhau, and 9 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-7291305/v1 This work is licensed under a CC BY 4.0 License Status: Published Journal Publication published 25 Mar, 2026 Read the published version in Nature Communications → Version 1 posted You are reading this latest preprint version Abstract Acute myeloid leukemia (AML) remains a formidable clinical challenge due to genetic heterogeneity, high relapse rates, and toxicities associated with conventional chemotherapies. Rationally designed drug combinations offer improved efficacy, yet their selection is often empirical and lacks molecular mechanistic understanding. Here, we present our workflow for Combinatorial Proteome Integral Solubility/Stability Alteration analysis (CoPISA), a high-throughput proteomics workflow that captures protein solubility/stability alterations unique to combinatorial drug treatments, revealing mechanisms unattainable through single-drug analyses. Applying CoPISA to two rationally designed AML drug pairs, LY3009120-sapanisertib (LS) and ruxolitinib-ulixertinib (RU), we mapped primary (lysate) and secondary (living cell) protein target landscapes. Notably, our analysis uncovered an emergent mechanistic principle, “conjunctional targeting” (i.e., conjunctional inhibition), wherein cooperative drug actions induce treatment-specific targets not achievable individually, analogous to an AND-gate logic model. LS-specific AND-gate proteins converged on SUMOylation, chromatin condensation, and VEGF-linked adhesion, while RU-specific targets disrupted DNA-damage checkpoints, mitochondrial bioenergetics, and RNA-splicing machinery, collectively implicating synthetic-lethal vulnerabilities. Additionally, the post-translational modifications (PTMs) profiling of differential soluble proteins confirms several combination-induced modifications (e.g., acetylation, dimethylation, phosphorylation) on key AML proteins, such as NPM1. Network interrogation of AML-associated proteins showed that a high percentage of targeted proteins are unique to the combinations, including frequently mutated drivers DNMT3A, NPM1, and TP53. CoPISA exposes how drug pairs enact multi-axis pressure on AML cells through conjunctional targeting, a mechanistic layer beyond classical synergy. By pinpointing combination-exclusive protein targets and signaling pathways, CoPISA provides a blueprint for precision-guided regimen design in AML and other heterogeneous cancers. Data are available via ProteomeXchange with identifier PXD066812. Biological sciences/Chemical biology/Proteomics Biological sciences/Cancer/Cancer therapy Full Text Additional Declarations There is NO Competing Interest. Supplementary Files SupplementaryFileS1.xlsx Supplementary_File_S1 SupplementaryFileS2.xlsx Supplementary_File_S2 SupplementaryFileS3.xlsx Supplementary_File_S3 SupplementaryFileS4.xlsx Supplementary_File_S4 SupplementaryFigures.docx Supplementary Figures Cite Share Download PDF Status: Published Journal Publication published 25 Mar, 2026 Read the published version in Nature Communications → Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-7291305","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Article","associatedPublications":[],"authors":[{"id":500197508,"identity":"e823e078-f05c-403d-a6c1-295e4fdbff55","order_by":0,"name":"Mohieddin Jafari","email":"data:image/png;base64,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","orcid":"https://orcid.org/0000-0002-6991-8587","institution":"University of Helsinki","correspondingAuthor":true,"prefix":"","firstName":"Mohieddin","middleName":"","lastName":"Jafari","suffix":""},{"id":500197509,"identity":"13974e2a-8025-42f5-ae19-d60e941390c7","order_by":1,"name":"Elham Gholizadeh","email":"","orcid":"","institution":"Department Biochemistry and Developmental Biology, University of Helsinki, Helsinki, Finland","correspondingAuthor":false,"prefix":"","firstName":"Elham","middleName":"","lastName":"Gholizadeh","suffix":""},{"id":500197510,"identity":"98b33b2e-9a68-476b-8f4c-4f12ee56564a","order_by":2,"name":"Ehsan Zangene","email":"","orcid":"","institution":"Department Biochemistry and Developmental Biology, University of Helsinki, Helsinki, Finland","correspondingAuthor":false,"prefix":"","firstName":"Ehsan","middleName":"","lastName":"Zangene","suffix":""},{"id":500197511,"identity":"cfb83327-d88b-44fe-ae85-97258f14f622","order_by":3,"name":"Uladzislau Vadadokhau","email":"","orcid":"","institution":"Department Biochemistry and Developmental Biology, University of Helsinki, Helsinki, Finland","correspondingAuthor":false,"prefix":"","firstName":"Uladzislau","middleName":"","lastName":"Vadadokhau","suffix":""},{"id":500197512,"identity":"13915817-d5b1-4f7a-8da8-539ee17ba702","order_by":4,"name":"Danilo Ritz","email":"","orcid":"","institution":"Biozentrum, University of Basel, Basel, Switzerland;","correspondingAuthor":false,"prefix":"","firstName":"Danilo","middleName":"","lastName":"Ritz","suffix":""},{"id":500197513,"identity":"dc0f57a2-3b74-4a1b-b35d-b27d90475da5","order_by":5,"name":"Juho Miettinen","email":"","orcid":"","institution":"Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland","correspondingAuthor":false,"prefix":"","firstName":"Juho","middleName":"","lastName":"Miettinen","suffix":""},{"id":500197514,"identity":"85338d90-d6b7-4b0a-a104-9718c49e6ac3","order_by":6,"name":"Rabah Soliymani","email":"","orcid":"https://orcid.org/0000-0003-0184-3352","institution":"Department Biochemistry and Developmental Biology, University of Helsinki, Helsinki, Finland","correspondingAuthor":false,"prefix":"","firstName":"Rabah","middleName":"","lastName":"Soliymani","suffix":""},{"id":500197515,"identity":"672000ef-1e9c-428e-b386-279468e528db","order_by":7,"name":"Marc Baumann","email":"","orcid":"","institution":"Department Biochemistry and Developmental Biology, University of Helsinki, Helsinki, Finland","correspondingAuthor":false,"prefix":"","firstName":"Marc","middleName":"","lastName":"Baumann","suffix":""},{"id":500197516,"identity":"52d37522-9582-4e55-b7b2-f8c333c952aa","order_by":8,"name":"Mathias Wilhelm","email":"","orcid":"https://orcid.org/0000-0002-9224-3258","institution":"Technical University of Munich","correspondingAuthor":false,"prefix":"","firstName":"Mathias","middleName":"","lastName":"Wilhelm","suffix":""},{"id":500197517,"identity":"aa53f1a7-ba70-427b-9a3f-ae88a5193b9f","order_by":9,"name":"Esko Kankuri","email":"","orcid":"https://orcid.org/0000-0002-2193-8773","institution":"University of Helsinki, Faculty of Medicine","correspondingAuthor":false,"prefix":"","firstName":"Esko","middleName":"","lastName":"Kankuri","suffix":""},{"id":500197518,"identity":"24f26dff-3197-4b76-a296-85455e188ff0","order_by":10,"name":"Paul Haynes","email":"","orcid":"","institution":"School of Natural Sciences, Macquarie University, North Ryde, New South Wales 2109, Australia","correspondingAuthor":false,"prefix":"","firstName":"Paul","middleName":"","lastName":"Haynes","suffix":""},{"id":500197519,"identity":"6ed497de-74bf-4242-8b7a-64c804eeab04","order_by":11,"name":"Caroline Heckman","email":"","orcid":"https://orcid.org/0000-0002-4324-8706","institution":"University of Helsinki","correspondingAuthor":false,"prefix":"","firstName":"Caroline","middleName":"","lastName":"Heckman","suffix":""},{"id":500197520,"identity":"ed98311b-69ed-49f5-a74e-742c109ccdcd","order_by":12,"name":"Amir Saei","email":"","orcid":"","institution":"Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.","correspondingAuthor":false,"prefix":"","firstName":"Amir","middleName":"","lastName":"Saei","suffix":""}],"badges":[],"createdAt":"2025-08-04 12:50:19","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-7291305/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-7291305/v1","draftVersion":[],"editorialEvents":[{"content":"https://doi.org/10.1038/s41467-026-70394-3","type":"published","date":"2026-03-25T04:00:00+00:00"}],"editorialNote":"","failedWorkflow":false,"files":[{"id":105445286,"identity":"e4bbc6aa-18dd-49ac-a0f2-6a2bbe0f5ae0","added_by":"auto","created_at":"2026-03-26 07:07:11","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":3959948,"visible":true,"origin":"","legend":"Article File","description":"","filename":"CoPiSAdraftmanuscript4.pdf","url":"https://assets-eu.researchsquare.com/files/rs-7291305/v1_covered_1c75ef8f-b187-4c03-a555-dd45396e5833.pdf"},{"id":89621348,"identity":"ca4606c3-cf71-4836-a26c-881913161b9a","added_by":"auto","created_at":"2025-08-22 04:09:55","extension":"xlsx","order_by":1,"title":"","display":"","copyAsset":false,"role":"supplement","size":571688,"visible":true,"origin":"","legend":"Supplementary_File_S1","description":"","filename":"SupplementaryFileS1.xlsx","url":"https://assets-eu.researchsquare.com/files/rs-7291305/v1/484887308862b3d0c737f41e.xlsx"},{"id":89621350,"identity":"3f1fed12-de9d-4a00-92df-db495d66976e","added_by":"auto","created_at":"2025-08-22 04:09:55","extension":"xlsx","order_by":2,"title":"","display":"","copyAsset":false,"role":"supplement","size":35144,"visible":true,"origin":"","legend":"Supplementary_File_S2","description":"","filename":"SupplementaryFileS2.xlsx","url":"https://assets-eu.researchsquare.com/files/rs-7291305/v1/e27d488f2b016aad16b2823f.xlsx"},{"id":89621652,"identity":"0e095e91-37e2-4041-892f-cd85efd6ccfd","added_by":"auto","created_at":"2025-08-22 04:17:55","extension":"xlsx","order_by":3,"title":"","display":"","copyAsset":false,"role":"supplement","size":29331,"visible":true,"origin":"","legend":"\u003cp\u003eSupplementary_File_S3\u003c/p\u003e","description":"","filename":"SupplementaryFileS3.xlsx","url":"https://assets-eu.researchsquare.com/files/rs-7291305/v1/d3421c5348a06eb6d0fe0743.xlsx"},{"id":89621346,"identity":"619cb80d-1352-4828-a478-00893745685e","added_by":"auto","created_at":"2025-08-22 04:09:55","extension":"xlsx","order_by":4,"title":"","display":"","copyAsset":false,"role":"supplement","size":7867,"visible":true,"origin":"","legend":"\u003cp\u003eSupplementary_File_S4\u003c/p\u003e","description":"","filename":"SupplementaryFileS4.xlsx","url":"https://assets-eu.researchsquare.com/files/rs-7291305/v1/d782da01449120b0bfc7164d.xlsx"},{"id":89621349,"identity":"24d6c79e-babe-4e74-861c-a005f911a1db","added_by":"auto","created_at":"2025-08-22 04:09:55","extension":"docx","order_by":5,"title":"","display":"","copyAsset":false,"role":"supplement","size":1054021,"visible":true,"origin":"","legend":"\u003cp\u003eSupplementary Figures\u003c/p\u003e","description":"","filename":"SupplementaryFigures.docx","url":"https://assets-eu.researchsquare.com/files/rs-7291305/v1/a616068088e5b9cb66355e5b.docx"}],"financialInterests":"There is \u003cb\u003eNO\u003c/b\u003e Competing Interest.","formattedTitle":"Shifting Beyond Classical Drug Synergy in Combinatorial Therapy through Solubility Alterations","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":true,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":true,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"nature-portfolio","isNatureJournal":true,"hasQc":false,"allowDirectSubmit":false,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"","title":"Nature Portfolio","twitterHandle":"","acdcEnabled":false,"dfaEnabled":false,"editorialSystem":"ejp","reportingPortfolio":"","inReviewEnabled":true,"inReviewRevisionsEnabled":false},"keywords":"","lastPublishedDoi":"10.21203/rs.3.rs-7291305/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-7291305/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"Acute myeloid leukemia (AML) remains a formidable clinical challenge due to genetic heterogeneity, high relapse rates, and toxicities associated with conventional chemotherapies. Rationally designed drug combinations offer improved efficacy, yet their selection is often empirical and lacks molecular mechanistic understanding. Here, we present our workflow for Combinatorial Proteome Integral Solubility/Stability Alteration analysis (CoPISA), a high-throughput proteomics workflow that captures protein solubility/stability alterations unique to combinatorial drug treatments, revealing mechanisms unattainable through single-drug analyses. Applying CoPISA to two rationally designed AML drug pairs, LY3009120-sapanisertib (LS) and ruxolitinib-ulixertinib (RU), we mapped primary (lysate) and secondary (living cell) protein target landscapes. Notably, our analysis uncovered an emergent mechanistic principle, “conjunctional targeting” (i.e., conjunctional inhibition), wherein cooperative drug actions induce treatment-specific targets not achievable individually, analogous to an AND-gate logic model. LS-specific AND-gate proteins converged on SUMOylation, chromatin condensation, and VEGF-linked adhesion, while RU-specific targets disrupted DNA-damage checkpoints, mitochondrial bioenergetics, and RNA-splicing machinery, collectively implicating synthetic-lethal vulnerabilities. Additionally, the post-translational modifications (PTMs) profiling of differential soluble proteins confirms several combination-induced modifications (e.g., acetylation, dimethylation, phosphorylation) on key AML proteins, such as NPM1. Network interrogation of AML-associated proteins showed that a high percentage of targeted proteins are unique to the combinations, including frequently mutated drivers DNMT3A, NPM1, and TP53. CoPISA exposes how drug pairs enact multi-axis pressure on AML cells through conjunctional targeting, a mechanistic layer beyond classical synergy. By pinpointing combination-exclusive protein targets and signaling pathways, CoPISA provides a blueprint for precision-guided regimen design in AML and other heterogeneous cancers. Data are available via ProteomeXchange with identifier PXD066812.","manuscriptTitle":"Shifting Beyond Classical Drug Synergy in Combinatorial Therapy through Solubility Alterations","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2025-08-22 04:09:51","doi":"10.21203/rs.3.rs-7291305/v1","editorialEvents":[],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"nature-communications","isNatureJournal":true,"hasQc":false,"allowDirectSubmit":false,"externalIdentity":"NCOMMS","sideBox":"Learn more about [Nature Communications](http://www.nature.com/ncomms/)","snPcode":"","submissionUrl":"https://mts-ncomms.nature.com/","title":"Nature Communications","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"ejp","reportingPortfolio":"Nature Communications","inReviewEnabled":true,"inReviewRevisionsEnabled":false}}],"origin":"","ownerIdentity":"26085ce9-be42-4ff9-a3fc-d48ff31dab7e","owner":[],"postedDate":"August 22nd, 2025","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"published-in-journal","subjectAreas":[{"id":53136111,"name":"Biological sciences/Chemical biology/Proteomics"},{"id":53136112,"name":"Biological sciences/Cancer/Cancer therapy"}],"tags":[],"updatedAt":"2026-03-26T07:07:03+00:00","versionOfRecord":{"articleIdentity":"rs-7291305","link":"https://doi.org/10.1038/s41467-026-70394-3","journal":{"identity":"nature-communications","isVorOnly":false,"title":"Nature Communications"},"publishedOn":"2026-03-25 04:00:00","publishedOnDateReadable":"March 25th, 2026"},"versionCreatedAt":"2025-08-22 04:09:51","video":"","vorDoi":"10.1038/s41467-026-70394-3","vorDoiUrl":"https://doi.org/10.1038/s41467-026-70394-3","workflowStages":[]},"version":"v1","identity":"rs-7291305","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-7291305","identity":"rs-7291305","version":["v1"]},"buildId":"XKTyCvWXoU3ODBz1xrDgd","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}